Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.

BACKGROUND AND PURPOSE: Stroke risk increases with age in patients who have nonvalvular atrial fibrillation. It is uncertain whether the efficacy of stroke prevention therapies in atrial fibrillation changes as patients age. The objective of this study was to determine the effect of age on the relat...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	van Walraven, C, Hart, R, Connolly, S, Austin, P, Mant, J, Hobbs, F, Koudstaal, P, Petersen, P, Perez-Gomez, F, Knottnerus, J, Boode, B, Ezekowitz, MD, Singer, D
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2009

Gelijkaardige items

Stroke prevention in atrial fibrillation
door: Hobbs, F
Gepubliceerd in: (2003)

Challenges of stroke prevention in patients with atrial fibrillation in clinical practice.
door: Hobbs, F, et al.
Gepubliceerd in: (2011)

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
door: Mant, J, et al.
Gepubliceerd in: (2007)

Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation
door: Taral K. Patel, et al.
Gepubliceerd in: (2012-01-01)

Should we screen for atrial fibrillation?
door: Lown, M, et al.
Gepubliceerd in: (2017)

Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
door: Mavaddat, N, et al.
Gepubliceerd in: (2014)

Atrial fibrillation and stroke prevention: where we are and where we should be
door: Jones, N, et al.
Gepubliceerd in: (2018)

Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation
door: Fareed Moses S. Collado, et al.
Gepubliceerd in: (2021-11-01)

New possibilities in the prevention of stroke in atrial fibrillation
door: Vladimir Anatolyevich Parfenov, et al.
Gepubliceerd in: (2012-03-01)

The risk factors and prevention of stroke in atrial fibrillation
door: V. A. Parfenov, et al.
Gepubliceerd in: (2014-10-01)

Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation
door: Ziad Hijazi, et al.
Gepubliceerd in: (2020-12-01)

Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
door: Christian Mahnkopf, et al.
Gepubliceerd in: (2021-12-01)

Treatment pathways for patients with atrial fibrillation.
door: Hodgkinson, J, et al.
Gepubliceerd in: (2012)

Stroke and atrial fibrillation: An update
door: Nicole Beaton Sur, et al.
Gepubliceerd in: (2022-10-01)

Atrial Fibrillation Related and Unrelated Stroke Recurrence Among Ischemic Stroke Patients With Atrial Fibrillation
door: Bum Joon Kim, et al.
Gepubliceerd in: (2021-10-01)

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
door: Mant, J, et al.
Gepubliceerd in: (2003)

Atrial fibrillation fact sheet in Korea 2024: part 2—stroke prevention in Korean patients with atrial fibrillation
door: Pil-sung Yang, et al.
Gepubliceerd in: (2024-08-01)

Anticoagulant management in patients with atrial fibrillation.
door: Fitzmaurice, D, et al.
Gepubliceerd in: (2009)

Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".
door: Mavaddat, N, et al.
Gepubliceerd in: (2014)

SPARC - stroke prevention in atrial fibrillation risk calculator
door: Catarina Matias
Gepubliceerd in: (2011-03-01)

Prognosis and prevention of cardioembolic stroke in patients with atrial fibrillation
door: V. А. Parfyonov, et al.
Gepubliceerd in: (2013-12-01)

Stroke Prevention in Atrial Fibrillation: Current Strategies and Recommendations
door: Gerald V. Naccarelli, et al.
Gepubliceerd in: (2016-01-01)

Stroke Prevention in Atrial Fibrillation: Where are We Now?
door: Yousif Ahmad, et al.
Gepubliceerd in: (2012-01-01)

Stroke Prevention in Atrial Fibrillation: Focus on Latin America
door: Ayrton R. Massaro, et al.
Gepubliceerd in: (2016-01-01)

Emerging options to prevent stroke in atrial fibrillation patients
door: Silver B
Gepubliceerd in: (2012-01-01)

Prevention of stroke in patients with atrial fibrillation by an atrial assistance device - an upstream therapy?
door: Swiss Medical Weekly
Gepubliceerd in: (2009-02-01)

Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction
door: Jodi D. Edwards, et al.
Gepubliceerd in: (2020-06-01)

Hybrid decision support to monitor atrial fibrillation for stroke prevention
door: Lei, Ningrong, et al.
Gepubliceerd in: (2021)

Is warfarin a safe alternative to aspirin in elderly patients with atrial fibrillation?
door: Mant, J, et al.
Gepubliceerd in: (2008)

Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation and Hereditary Hemorrhagic Telangiectasia
door: Sebastiaan Velthuis, et al.
Gepubliceerd in: (2012-01-01)

Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial.
door: Mant, J, et al.
Gepubliceerd in: (2007)

Residual Stroke Risk in Atrial Fibrillation
door: Wern Yew Ding
Gepubliceerd in: (2021-10-01)

Atrial Fibrillation and Stroke in Elderly Patients
door: Geetanjali Dang, et al.
Gepubliceerd in: (2016-11-01)

Stroke as the First Manifestation of Atrial Fibrillation.
door: Jussi Jaakkola, et al.
Gepubliceerd in: (2016-01-01)

Device‐Detected Atrial Fibrillation and the Impact of Prior Stroke in Stroke Prevention
door: James E. Siegler, et al.
Gepubliceerd in: (2024-09-01)

Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland
door: Mark Pletscher, et al.
Gepubliceerd in: (2012-12-01)

The problem of choosing an anticoagulant for stroke prevention in patients with atrial fibrillation
door: EL Dolgova, et al.
Gepubliceerd in: (2014-12-01)

Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation
door: Josef Finsterer, et al.
Gepubliceerd in: (2012-02-01)

Thermally responsive hydrogel for atrial fibrillation related stroke prevention
door: Troy Hendrickson, et al.
Gepubliceerd in: (2022-03-01)

Atrial fibrillation does not equal atrial fibrillation: The important prognostic implications of new-onset atrial fibrillation
door: Andreas Goette, et al.
Gepubliceerd in: (2025-02-01)